Statement of Income (Including Gross Margin) |
3 Months Ended | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||
| Income Statement [Abstract] | |||||||||||||||||||||||||||||||
| Restructuring and Related Activities Disclosure | Restructuring and Impairment Charges In connection with the restructuring program initiated in 2024 to optimize the Company's manufacturing footprint, the Company recognized $1.6 million of other-related costs and $0.2 million for employee-severance and other-related costs during the three months ended March 31, 2026 and 2025, respectively. These costs are included in "Restructuring and impairment charges" in the unaudited condensed consolidated statements of operations. The Company expects to execute this 2024 program through 2026 and 2027 and expects to incur an additional $10 million to $12 million through the end of 2026, and between $3 million to $6 million in 2027. Following is the detail of the cash payments made under the Company's restructuring programs(a) related to severance:
|
||||||||||||||||||||||||||||||